CRISPR prevents hearing loss in mice
Researchers use CRISPR-Cas9 to target a mutation in the Tmc1 gene that causes the loss of hair cells in the inner ear.
List view / Grid view
Researchers use CRISPR-Cas9 to target a mutation in the Tmc1 gene that causes the loss of hair cells in the inner ear.
Drug discovery from concept to drug candidate has become a collective effort where multi-disciplinary project teams from CROs work with drug companies and academia to deliver clinical candidates, overcoming multi-factorial research obstacles along the way.
Charles River Laboratories International, Inc. announced the expansion of its CRISPR/Cas9 service offering with the addition of a license from ERS Genomics Limited.
An unexpected drug target for acute myeloid leukaemia could open new avenues to develop effective treatments against the potentially lethal disease...
Nanomapping technology may transform the way disease-causing genetic mutations are diagnosed and discovered...
New delivery system deletes disease-causing genes and reduces cholesterol...
Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to become abnormal...
Charles River Laboratories International, Inc. announced that its team of neuroscience drug discovery experts is presenting 27 scientific posters, both independently and collaboratively with clients, at Neuroscience 2017, the 47th annual meeting of the Society for Neuroscience (SfN).
New 'REPAIR' system edits RNA, rather than DNA, without permanently affecting the genome...
CRISPR used to identify a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies...
Biological engineers identify genes that protect against protein linked to Parkinson's disease...
Researchers have found that polymer and hybrid silica-coated microcapsules are efficient in genome-editing...
A new technique for modelling leukaemia may aid drug discovery...
Researchers have used CRISPR-Cas9 to inactivate genes in human colorectal cancer cell lines -- one with normal KRAS gene and one with a mutant KRAS...
Researchers have used genome editing technology to reveal the role of a key gene in human embryos in the first few days of development...